Pelargonium sidoides (Umckaloabo)
Umckaloabo (Pelargonium sidoides) is a South African geranium extract containing gallic acid, catechin, and proanthocyanidins that combat respiratory infections. Its active compounds inhibit bacterial adhesion to mucous membranes while stimulating interferon production and macrophage activity.

Origin & History
Pelargonium sidoides, commonly known as Umckaloabo, is a plant native to Southern Africa. It is traditionally harvested for its roots, which are used in various forms, such as liquid extracts and capsules.
Historical & Cultural Context
Pelargonium sidoides has been used in African traditional medicine for centuries to treat respiratory ailments. It is valued for its potential to alleviate symptoms and promote recovery.
Health Benefits
- Boosts respiratory health by reducing bronchial inflammation, easing breathing. - Enhances immune response by increasing antibody production, fighting infections. - Supports sinus health by reducing mucus production, clearing nasal passages. - Provides antioxidant protection by neutralizing free radicals, supporting cellular health. - Improves mood by modulating neurotransmitter levels, enhancing mental well-being. - Aids in managing colds by shortening duration, reducing symptom severity. - Supports cardiovascular health by improving blood flow, reducing heart strain.
How It Works
Umckaloabo's gallic acid and proanthocyanidins prevent bacterial and viral adhesion to respiratory epithelial cells while disrupting biofilm formation. The extract stimulates interferon-γ production, enhances natural killer cell activity, and increases secretory IgA in respiratory mucosa. Catechin compounds provide additional antioxidant protection by scavenging reactive oxygen species.
Scientific Research
Some studies, including randomized controlled trials, suggest Pelargonium sidoides may be effective in reducing symptoms and duration of respiratory infections, such as bronchitis and the common cold.
Clinical Summary
Multiple randomized controlled trials involving over 2,000 participants demonstrate umckaloabo's efficacy for acute bronchitis and upper respiratory infections. Studies show 40-50% reduction in bronchitis severity scores and 2-3 day shorter symptom duration compared to placebo. Meta-analyses confirm significant benefits for acute rhinosinusitis and common cold symptoms. Most trials used standardized EPs 7630 extract at 30-60mg daily for 7-10 days.
Nutritional Profile
Pelargonium sidoides is not consumed as a food source but rather as a medicinal preparation (root extract), so traditional macronutrient profiling is not applicable. The root is rich in distinct bioactive compounds: **Polyphenols & Coumarins** — contains umckalin (7-hydroxy-5,6-dimethoxycoumarin, ~0.01–0.05% dry weight), scopoletin (~0.005–0.02%), and 6,8-dihydroxy-5,7-dimethoxycoumarin; these are the primary immunomodulatory agents. **Proanthocyanidins (condensed tannins)** — prodelphinidins and procyanidins constitute approximately 5–12% of the dry root extract (EPs 7630 standardized extract), responsible for significant antiviral and antibacterial activity. **Gallic acid and gallic acid derivatives** — including gallic acid methyl ester (~0.1–0.5%), contributing to antioxidant capacity. **Simple phenolic acids** — caffeic acid, p-coumaric acid, and their glycosides in trace amounts. **Minerals** — calcium (~200–400 mg/100g dry root), potassium (~300–600 mg/100g), magnesium (~80–150 mg/100g), iron (~5–15 mg/100g), and zinc (~2–5 mg/100g); values vary with soil conditions. **Carbohydrates** — mucilaginous polysaccharides (~3–8% dry weight) with potential prebiotic activity. **Tannin content** — total tannins range from 8–15% in dried root material, which can reduce bioavailability of co-consumed minerals and proteins. **Vitamins** — negligible; not a meaningful source of any vitamin. **Protein & fat** — minimal; root contains roughly 3–6% crude protein and <1% lipids. **Fiber** — crude fiber approximately 15–25% of dry root material. **Bioavailability notes** — The standardized hydroethanolic extract (EPs 7630, 11% ethanol w/w) significantly enhances the solubility and absorption of coumarins and proanthocyanidins compared to crude root powder. Umckalin and related coumarins are moderately bioavailable orally; prodelphinidins have lower systemic bioavailability but exert local effects in the gastrointestinal and respiratory mucosa. High tannin content may bind dietary iron and proteins if taken with meals, so administration on an empty stomach is generally recommended for optimal bioactive absorption.
Preparation & Dosage
Typical dosage is 30-60 drops of extract three times daily. Consult a healthcare provider before use.
Synergy & Pairings
Echinacea, Elderberry, Ginger
Safety & Interactions
Umckaloabo is generally well-tolerated with mild gastrointestinal upset reported in 5-8% of users. Rare cases of liver enzyme elevation have been documented, requiring monitoring in individuals with hepatic conditions. The extract may enhance warfarin activity due to coumarin content, necessitating INR monitoring. Pregnancy and breastfeeding safety data are insufficient, warranting avoidance during these periods.